Chiarella, E.; Nisticò, C.; Di Vito, A.; Morrone, H.L.; Mesuraca, M.
Targeting of Mevalonate-Isoprenoid Pathway in Acute Myeloid Leukemia Cells by Bisphosphonate Drugs. Biomedicines 2022, 10, 1146.
https://doi.org/10.3390/biomedicines10051146
AMA Style
Chiarella E, Nisticò C, Di Vito A, Morrone HL, Mesuraca M.
Targeting of Mevalonate-Isoprenoid Pathway in Acute Myeloid Leukemia Cells by Bisphosphonate Drugs. Biomedicines. 2022; 10(5):1146.
https://doi.org/10.3390/biomedicines10051146
Chicago/Turabian Style
Chiarella, Emanuela, Clelia Nisticò, Anna Di Vito, Helen Linda Morrone, and Maria Mesuraca.
2022. "Targeting of Mevalonate-Isoprenoid Pathway in Acute Myeloid Leukemia Cells by Bisphosphonate Drugs" Biomedicines 10, no. 5: 1146.
https://doi.org/10.3390/biomedicines10051146
APA Style
Chiarella, E., Nisticò, C., Di Vito, A., Morrone, H. L., & Mesuraca, M.
(2022). Targeting of Mevalonate-Isoprenoid Pathway in Acute Myeloid Leukemia Cells by Bisphosphonate Drugs. Biomedicines, 10(5), 1146.
https://doi.org/10.3390/biomedicines10051146